# BioExx Specialty Proteins Ltd.: Form D filings

BioExx Specialty Proteins Ltd., a biotechnology company in Toronto, Ontario, Canada, filed 5 Form D notices with the SEC between 2009 and 2011. The latest, on July 15, 2011, reports $2.3 million sold of a $2.3 million offering to 4 investors.

Find out what BioExx Specialty Proteins Ltd. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20BioExx%20Specialty%20Proteins%20Ltd.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=BioExx%20Specialty%20Proteins%20Ltd.&page=%2Fdata%2Fform-d%2Fcompany%2Fbioexx-specialty-proteins-ltd-1465222)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20BioExx%20Specialty%20Proteins%20Ltd.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=BioExx%20Specialty%20Proteins%20Ltd.&page=%2Fdata%2Fform-d%2Fcompany%2Fbioexx-specialty-proteins-ltd-1465222)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 219 DUFFERIN STREET, SUITE 100B, Toronto, Ontario, Canada, M6K 3
- Phone: (416) 588-4442
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Ontario, Canada
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1465222

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jul 15, 2011 | New notice | $2,284,354 | $2,284,354 | $0 | 4 | Jun 30, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1465222/000120445911001910/0001204459-11-001910-index.htm) |
| Sep 8, 2010 | New notice | $1,524,806 | $1,524,806 | $0 | 7 | Aug 24, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1465222/000120445910002148/0001204459-10-002148-index.htm) |
| Apr 16, 2010 | New notice | $1,313,218 | $1,313,218 | $0 | 3 | Mar 30, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1465222/000120445910000836/0001204459-10-000836-index.htm) |
| Nov 9, 2009 | New notice | $3,771,308 | $3,771,308 | $0 | 21 | Oct 15, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1465222/000120445909002050/0001204459-09-002050-index.htm) |
| Jun 10, 2009 | New notice | $827,608 | $827,608 | $0 | 4 | May 14, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1465222/000120445909001072/0001204459-09-001072-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Will D. Ollerhead | Director |  |
| Samah D. Garringer | Executive Officer |  |
| John D. MacDonald | Director |  |
| Christopher D. Carl | Executive Officer, Director |  |
| Henry D. Linsert | Director |  |
| Peter D. Lacey | Director |  |
| Chris D. Schnarr | Executive Officer, Director |  |
| Clinton D. Smith | Executive Officer |  |

[Every Form D from the week of Jul 11, 2011](https://specstream.ai/data/form-d/week/2011-07-11) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what BioExx Specialty Proteins Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).